Clinical trial
Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial
NCT06007222 is registered in ClinicalTrials.gov with OCEAN-SHD Study Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial
- Lead sponsor
- OCEAN-SHD Study Group
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- April 6, 2023
- Completion date
- December 31, 2027
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aortic stenosis, aspirin, dapt(dual antiplatelet therapy), sapt(single antiplatelet therapy), tavi(transcatheter aortic valve implantation)